Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05752448 · ClinicalTrials.gov registry record · NA
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
A NA study of Quality of Life and Depressive Symptoms, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT05752448: Recruiting NA study of Quality of Life and Depressive Symptoms, sponsored by Baylor College of Medicine.
NCT05752448 is a NA study of Quality of Life and Depressive Symptoms that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 120 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05752448, a NA study of Quality of Life and Depressive Symptoms, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.
Primary Outcome
Quality of life measured by Functional Assessment of Cancer Therapy - Ovarian instrument composite scorecomprised of physical, emotional, functional, social, and disease specific subscales. Scoring range 0 - 152; a higher score indicates better quality of life.
Conditions Studied
Interventions
- BEHAVIORAL POSTCare Survivorship transition process
Study Locations (3)
Texas
- UT Southwestern Parkland Health and Hospital System - Dallas
- Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center - Houston
- Harris Health Smith Clinic - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2027-04-15 |
| Phase | NA |
What NCT05752448 shows while recruiting
NCT05752448 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (73% lower).
The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which POSTCare Survivorship transition process is the first listed.
NCT05752448 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05752448 about?
NCT05752448 is a clinical study titled "Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)". This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its ...
What is the current status of trial NCT05752448?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-10-01. Estimated completion is 2027-04-15.
What conditions does trial NCT05752448 study?
This clinical trial studies the following conditions: Quality of Life, Depressive Symptoms, Ovarian Neoplasm.
What interventions are being tested in trial NCT05752448?
The interventions under investigation include: POSTCare Survivorship transition process (BEHAVIORAL).
Who is sponsoring clinical trial NCT05752448?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05752448 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05752448's enrollment target sits among peer trials
120 42nd of 107 higher than 64 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI